Poly Medicure Ltd Falls to 52-Week Low of Rs.1555 Amid Sector and Market Weakness

Stock Price Movement and Market Context

On the trading day, Poly Medicure Ltd touched an intraday low of Rs.1555, marking its lowest level in the past year. The stock has been on a declining streak for two consecutive sessions, registering a cumulative loss of 5.44% over this period. The day’s closing price represented a 3.47% drop, aligning with the sector’s overall performance, where the Medical Equipment, Supplies, and Accessories segment fell by 3.75%.

Poly Medicure’s share price currently trades below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained bearish momentum. This technical positioning underscores the stock’s recent struggles relative to its historical price trends.

The broader market environment has also been challenging. The Sensex opened 385.82 points lower and was trading at 81,768.08 by mid-session, down 0.5%. Notably, the Sensex has experienced a three-week consecutive decline, losing 4.66% in that timeframe. While the Sensex remains above its 200-day moving average, it is currently below its 50-day average, indicating some near-term pressure.

Financial Performance and Valuation Metrics

Over the past year, Poly Medicure Ltd’s stock has underperformed significantly, delivering a negative return of 37.51%, in stark contrast to the Sensex’s positive 7.83% gain and the BSE500’s 6.04% rise. Despite this, the company’s profits have increased by 22.8% during the same period, indicating a divergence between earnings growth and market valuation.

The company’s return on equity (ROE) stands at 12.4%, while its price-to-book (P/B) ratio is elevated at 5.7, suggesting a relatively expensive valuation compared to historical norms. The PEG ratio is calculated at 2, reflecting the relationship between price, earnings growth, and valuation.

Dividend payout ratio (DPR) is notably low at 10.70%, and the debtors turnover ratio for the half-year is at 4.02 times, both among the lowest in recent periods. These metrics may contribute to investor caution regarding cash flow and receivables management.

Sector Position and Market Capitalisation

Poly Medicure Ltd holds a market capitalisation of approximately Rs.16,556 crores, making it the second largest company in the Healthcare Services sector, trailing only Lenskart Solutions. The company accounts for 15.87% of the sector’s total market cap and contributes 15.86% of the industry’s annual sales, which total Rs.1,712.13 crores.

Institutional investors hold a significant stake of 23.31%, indicating a substantial presence of entities with advanced analytical capabilities. The company maintains a low average debt-to-equity ratio of zero, reflecting a conservative capital structure with minimal leverage.

Rating and Market Sentiment

MarketsMOJO currently assigns Poly Medicure Ltd a Mojo Score of 37.0, categorising it with a Sell grade as of 28 May 2025, a downgrade from its previous Hold rating. The market cap grade is 3, reflecting a mid-tier valuation within its peer group. This rating adjustment aligns with the stock’s recent price performance and financial indicators.

The stock’s 52-week high was Rs.2936.7, illustrating a substantial decline of nearly 47% from that peak to the current 52-week low. This wide price range highlights the volatility and challenges faced by the company’s shares over the past year.

Comparative Sector and Market Trends

The Healthcare Services sector, particularly the Medical Equipment and Supplies segment, has experienced downward pressure, with the sector index falling 3.75% on the day. Poly Medicure’s performance has been broadly in line with this trend, though its longer-term underperformance relative to the Sensex and BSE500 indices is notable.

While the Sensex remains above its 200-day moving average, its current position below the 50-day average and the three-week consecutive decline suggest a cautious market environment. Within this context, Poly Medicure’s stock has mirrored the broader market’s subdued tone.

Summary of Key Metrics

To recap, Poly Medicure Ltd’s stock has reached a new 52-week low of Rs.1555, following a two-day decline of 5.44%. The company’s financial profile includes a ROE of 12.4%, a low dividend payout ratio of 10.70%, and a debtors turnover ratio of 4.02 times. Its market capitalisation stands at Rs.16,556 crores, with institutional holdings at 23.31%. The stock trades below all major moving averages and carries a Mojo Score of 37.0 with a Sell rating.

These factors collectively illustrate the current challenges faced by Poly Medicure Ltd’s shares amid a broader sector and market downturn, reflected in both price action and fundamental metrics.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →